Articles > Popular publications > PR Newswire press releases > July-September 2006 > Monday, September 18

Article: Sirion Therapeutics, Inc. Combines With Tenby Pharma Inc.

Article from:
PR Newswire
Article date:
September 18, 2006
Copyright

Tenby Pharma Emerges with $25 Million in Financing

TAMPA, Fla., Sept. 18 /PRNewswire/ -- Tenby Pharma Inc. announced today its acquisition of Sirion Therapeutics, Inc. as a wholly owned subsidiary. From Tenby Pharma's inception until the consummation of the Sirion acquisition, Tenby Pharma was a shell company with no business or operations and only nominal assets. Pursuant to the transaction, Sirion's former stockholders acquired control of Tenby Pharma and Tenby Pharma became the parent holding company for Sirion and its businesses. Additionally, in connection with the transaction, Tenby Pharma secured $25 million in financing from funds affiliated with North ... 







Read all of this article with a FREE trial
















Related newspaper, magazine, and journal articles:









  




 

    

 
 
   
 


   
  
  Article: Tenby Pharma emerges with $25M ...

  
  Pharma Marketletter; 
  September 25, 2006 ;  
  
  
 
  700+ words
... ... Florida, USA-based Tenby Pharma has announced its acquisition of Sirion Therapeutics as a wholly-owned ... is anticipated that Tenby Pharma will undergo a name ... medical officer of Sirion Therapeutics, and Barry Butler ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Tenby Pharma changes name to Sirion.(Tenby ...

  
  Pharma Marketletter; 
  December 22, 2006 ;  
  
  
 
  647 words
... ... USA-based Tenby Pharma says that it ... transaction whereby Sirion Therapeutics became a wholly ... subsidiary. From Tenby Pharma's inception ... the deal, Tenby Pharma secured $25 ... subsidiary, Sirion Therapeutics," said Susan ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Tenby Pharma Changes Corporate Name to Sirion ...

  
  PR Newswire; 
  November 30, 2006 ;  
  
  
 
  572 words
... ... PRNewswire/ -- Tenby Pharma Inc. announced ... transaction whereby Sirion Therapeutics, Inc. became ... Tenby. From Tenby Pharma's inception ... transaction, Tenby Pharma secured $25 ... subsidiary, Sirion Therapeutics, Inc ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Sirion Gains $25M Through Takeover By Tenby Pharma.

  
  BIOWORLD Today; 
  September 19, 2006 ;  
  
  
 
  700+ words
...Byline: Randall Osborne, West Coast Editor Sirion Therapeutics Inc.'s buyout by the shell firm Tenby Pharma Inc., which will become Sirion's parent holding company, brings $25 million in financing from North Sound Capital LLC to ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Plenty More Behind Lead Drug.(Sirion Therapeutics ...

  
  BIOWORLD Today; 
  April 10, 2007 ;  
  
  
 
  700+ words
... ... Randall Osborne, West Coast Editor Ophthalmics-targeted Sirion Therapeutics Inc. pulled down $45 million in a Series B financing ... merging with Sytera, was taken over by the shell firm Tenby Pharma Inc., which became Sirion's parent holding company ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Sirion Therapeutics Acquires Worldwide License to ...

  
  PR Newswire; 
  February 20, 2008 ;  
  
  
 
  700+ words
... ... Feb. 20 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ... Chief Medical Officer of Sirion Therapeutics. Under the terms of this licensing agreement, Sirion Therapeutics will have the rights to manufacture ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Sirion Therapeutics Preclinical Studies: Two New ...

  
  PR Newswire; 
  April 21, 2008 ;  
  
  
 
  700+ words
... ... April 21 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic ... Barry Butler, President and CEO of Sirion Therapeutics, Inc. "Sirion's targeted research ... Durezol(TM) is the trademark of Sirion Therapeutics, Inc. and is currently under review ... 







   
 




  




 

    

 
 
   
 


   
  
  Article: Sirion Therapeutics Announces Clinical Data to be ...

  
  PR Newswire; 
  April 23, 2007 ;  
  
  
 
  700+ words
... ... April 23 /PRNewswire/ -- Sirion Therapeutics announced today that data on two ... President and Chief Executive Officer of Sirion Therapeutics. "This is exciting news for our ... ophthalmic therapies for unmet needs." Sirion Therapeutics Reception for all ARVO attendees ... 







   
 

























 



 





 






Newsweek
Harper's Magazine
The Washington Post
Chicago Tribune
Crain's Chicago Business
PRNewswire
Pediatric News
The Nation
Advertising Age
The Economist (US)
A FREE trial gives you access to over 80 million articles!
Access over 6,500 publications with a FREE trial!


  



Find articles, research, and archives